Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
Public ClinicalTrials.gov record NCT05579899. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Vehicle-controlled, Safety and Efficacy Study of EVO101 in Adult Subjects With Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2a safety and efficacy study of EVO101 for the treatment of adults with atopic dermatitis
Study identification
- NCT ID
- NCT05579899
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 119 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 26, 2022
- Primary completion
- Jul 26, 2023
- Completion
- Jul 26, 2023
- Last update posted
- Mar 4, 2025
2022 – 2023
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Saguaro Dermatology | Phoenix | Arizona | 85008 | — |
| Clinical Trials Institute of Northwest Arkansas | Fayetteville | Arkansas | 72703 | — |
| Northwest AR Clinical Trials Center, PLLC | Rogers | Arkansas | 72758 | — |
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| Metropolis Dermatology | Los Angeles | California | 90017 | — |
| Dermatology Research Associate | Los Angeles | California | 90045 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Driven Research, LLC | Coral Gables | Florida | 33134 | — |
| Lenus Research and Medical Group | Miami | Florida | 33172 | — |
| Dawes Fretzin Clinical Research Group | Indianapolis | Indiana | 46250 | — |
| The Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| Minnesota Clinical Study Center | New Brighton | Minnesota | 55112 | — |
| SkinSpecialists, LLC | Omaha | Nebraska | 69144 | — |
| JDR Dermatology Research, LLC | Las Vegas | Nevada | 89148 | — |
| Dermatology Consulting Services, PLLC | High Point | North Carolina | 27262 | — |
| Dermatologists of Southwest Ohio | Mason | Ohio | 45040 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| DermResearch | Austin | Texas | 78759 | — |
| J&S Studies, Inc | College Station | Texas | 77845 | — |
| Center for Clinical Studies, Ltd LLC | Houston | Texas | 77004 | — |
| Pariser Dermatology Specialists | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05579899, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05579899 live on ClinicalTrials.gov.